Dräger Launches Infinity® Acute Care System Monitoring Solution

Dräger has announced the availability of its breakthrough Infinity Acute Care System monitoring solution in the United States and Canada*. This system pairs a handheld device for monitoring at the bedside and in-hospital transport with a widescreen medical workstation at the point of care. The system provides continuous surveillance, interoperability with Dräger’s ventilation systems, comprehensive patient information at the bedside, and the full suite of Masimo’s rainbow® SET noninvasive Pulse CO-Oximetry measurements, which can help hospitals increase patient safety and reduce costs. The Infinity Acute Care System has been in commercial use in European hospitals since 2010.

Medical technology brings many benefits to the delivery of patient care, but it can also add unwelcomed complexity for caregivers. As a result, clinicians often spend more time dealing with technical interfaces and complicated workflow and less time focusing on direct patient care.

“At Dräger, our response to increased technical and clinical complexity is to explore ways we can simplify acute care delivery for clinicians,” says Marita Klafke, President, Draeger Medical Systems Inc. “The Infinity Acute Care System monitoring solution is designed to help streamline workflow so that the clinician can focus on the needs of the patient.”

First installation at Rush University Medical Center

The highly rated Rush University Medical Center in Chicago is the first US hospital to fully incorporate this advanced new patient monitoring system. Dräger worked closely with Rush staff as they developed the hospital’s new 376-bed building known as the Tower, where Dräger’s monitoring and IT technology is installed in 304 acute and critical care rooms.

The monitoring solution consists of a handheld Infinity M540 patient monitor integrated with the Dräger Medical Cockpit®. The M540 transitions seamlessly from the bedside to wireless transport, eliminating the time consuming process of changing monitors and cables. The Medical Cockpit integrates vital signs data from the M540, together with networked information such as patient history, diagnostic images, lab results, and other relevant networked clinical information into one widescreen display at the point of care. The system also enables ventilation parameters from Dräger ventilators to be displayed on the Medical Cockpit and sent over the network.

Wireless on transport

This fully networked solution allows a single monitor to accompany the patient during the entire care pathway to minimize undetected events. When the Infinity M540 is undocked at the bedside, it automatically switches to wireless and broadcasts patient vital signs data to the Infinity Network allowing uninterrupted monitoring during transport on the Infinity CentralStation. At the same time, it opens the flow of patient information throughout the hospital and beyond to support time-critical decision making.

Masimo rainbow® SET technology for noninvasive, continuous Pulse CO-Oximetry measurements

The Infinity M540 integrates Masimo rainbow® SET technology – a new monitoring platform that noninvasively and continuously measures multiple blood components and hemodynamic parameters that previously required invasive procedures. Dräger is one of the first major monitoring vendors to offer the full suite of Masimo’s rainbow® SET Pulse CO-Oximetry measurements.

The Infinity Acute Care System monitoring solution is manufactured by Draeger Medical Systems, Inc. in Andover, Massachusetts for Draeger Medical GmbH.

Dräger. Technology for Life®

Dräger is a leading international company in the fields of medical and safety technology. Dräger products protect, support and save lives. Founded in 1889, in 2011 Dräger generated revenues of around EUR 2.26 billion. The Dräger Group is currently present in more than 190 countries and has about 12,000 employees worldwide. Please visit www.draeger.comfor more information.

*The Infinity Acute Care System monitoring solution is pending Health Canada approval.